NO20030648L - Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav - Google Patents

Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav

Info

Publication number
NO20030648L
NO20030648L NO20030648A NO20030648A NO20030648L NO 20030648 L NO20030648 L NO 20030648L NO 20030648 A NO20030648 A NO 20030648A NO 20030648 A NO20030648 A NO 20030648A NO 20030648 L NO20030648 L NO 20030648L
Authority
NO
Norway
Prior art keywords
perfluoroalkyl
preparing
same
sugar residues
complexes containing
Prior art date
Application number
NO20030648A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030648D0 (no
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20030648D0 publication Critical patent/NO20030648D0/no
Publication of NO20030648L publication Critical patent/NO20030648L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030648A 2000-08-11 2003-02-10 Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav NO20030648L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040381A DE10040381C1 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2001/008499 WO2002014309A1 (de) 2000-08-11 2001-07-23 Perfluoralkylhaltige komplexe mit zuckerresten, verfahren zu deren herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO20030648D0 NO20030648D0 (no) 2003-02-10
NO20030648L true NO20030648L (no) 2003-04-11

Family

ID=7652861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030648A NO20030648L (no) 2000-08-11 2003-02-10 Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav

Country Status (30)

Country Link
EP (1) EP1307446B1 (cs)
JP (1) JP2004506631A (cs)
KR (1) KR100820387B1 (cs)
CN (1) CN1249058C (cs)
AR (1) AR035579A1 (cs)
AT (1) ATE293623T1 (cs)
AU (2) AU2001289729B2 (cs)
BG (1) BG107540A (cs)
BR (1) BR0113192A (cs)
CA (1) CA2418790A1 (cs)
CZ (1) CZ2003340A3 (cs)
DE (2) DE10040381C1 (cs)
DK (1) DK1307446T3 (cs)
EE (1) EE200300059A (cs)
ES (1) ES2240517T3 (cs)
HR (1) HRP20030172A2 (cs)
HU (1) HUP0300744A3 (cs)
IL (1) IL154328A0 (cs)
MX (1) MXPA03001285A (cs)
NO (1) NO20030648L (cs)
NZ (1) NZ524079A (cs)
PL (1) PL360359A1 (cs)
PT (1) PT1307446E (cs)
RU (1) RU2280644C2 (cs)
SK (1) SK1542003A3 (cs)
TW (1) TWI243170B (cs)
UA (1) UA75364C2 (cs)
WO (1) WO2002014309A1 (cs)
YU (1) YU10403A (cs)
ZA (1) ZA200301948B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE10260372B4 (de) 2002-12-13 2007-01-04 Schering Ag Kernspintomographievorrichtung und Verfahren zur ortsaufgelösten Bilddarstellung
WO2007009637A2 (de) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
JP2010507645A (ja) * 2006-10-25 2010-03-11 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 前立腺癌を検出するための造影剤
DE102008024976A1 (de) 2008-05-23 2009-12-17 Marvis Technologies Gmbh Medizinisches Instrument
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
EP2450067A1 (en) 2010-10-18 2012-05-09 MaRVis Technologies GmbH Medical device
EP2484388A1 (en) 2011-02-05 2012-08-08 MaRVis Technologies GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP2692365A1 (en) 2012-08-03 2014-02-05 MaRVis Medical GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
KR102934987B1 (ko) 2018-11-23 2026-03-09 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
GB2620653A (en) * 2022-03-16 2024-01-17 Wenzhou Institute Univ Of Chinese Academy Of Sciences Cyclic GD (III) complex, preparation method therefor and application thereof
CN119101100B (zh) * 2024-11-07 2025-01-24 四川大学华西医院 一种放射性核素药物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
CA2069886A1 (en) * 1989-10-23 1991-04-24 David Love Multi-site metal chelating agents
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
CA2160819A1 (en) * 1994-10-21 1996-04-22 Yuji Hashiguchi Diagnostic imaging agent
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
PT1307446E (pt) 2005-08-31
PL360359A1 (en) 2004-09-06
HUP0300744A2 (hu) 2003-09-29
ZA200301948B (en) 2004-06-25
DK1307446T3 (da) 2005-08-15
RU2280644C2 (ru) 2006-07-27
NZ524079A (en) 2005-10-28
HRP20030172A2 (en) 2005-04-30
TWI243170B (en) 2005-11-11
DE50105965D1 (de) 2005-05-25
BR0113192A (pt) 2003-07-15
KR100820387B1 (ko) 2008-04-08
HK1062016A1 (en) 2004-10-15
AU2001289729B2 (en) 2006-11-16
IL154328A0 (en) 2003-09-17
NO20030648D0 (no) 2003-02-10
CN1468234A (zh) 2004-01-14
ES2240517T3 (es) 2005-10-16
MXPA03001285A (es) 2004-05-17
CA2418790A1 (en) 2003-02-07
JP2004506631A (ja) 2004-03-04
EP1307446A1 (de) 2003-05-07
SK1542003A3 (en) 2003-10-07
AU8972901A (en) 2002-02-25
DE10040381C1 (de) 2002-06-06
UA75364C2 (en) 2006-04-17
HUP0300744A3 (en) 2009-01-28
EE200300059A (et) 2004-12-15
CZ2003340A3 (cs) 2003-09-17
WO2002014309A1 (de) 2002-02-21
YU10403A (sh) 2006-05-25
AR035579A1 (es) 2004-06-16
ATE293623T1 (de) 2005-05-15
BG107540A (bg) 2003-11-28
KR20030024855A (ko) 2003-03-26
CN1249058C (zh) 2006-04-05
EP1307446B1 (de) 2005-04-20

Similar Documents

Publication Publication Date Title
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20024281D0 (no) Indolderivater, fremgangsmåte for fremstilling av de samme og anvendelse derav
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
NO20030648D0 (no) Perfluoralkylholdige komplekser inneholdende sukkerresiduer, fremgangsmåtefor fremstilling av det samme og anvendelse derav
MXPA03000574A (es) Vidrios ceramizados, proceso para su preparacion y uso.
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
MXPA02010604A (es) Barra para limpieza personal y proceso de preparacion.
MXPA03000873A (es) Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
NO20013803L (no) Polymert adsorpsjonsmiddel og fremgangsmåte til fremstilling av samme
NO20030800D0 (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
MXPA03007848A (es) Derivados de quinolil propil piperidina, su preparacion y las composiciones que los contienen.
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
IL161428A0 (en) Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU2001289729A1 (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
EE200300060A (et) Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine
MXPA03006249A (es) Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
EP1415983A4 (en) 5-AMIDINO-N- (2-AMINOPHENETHYL) -N-HYDROXYBENZENSULFONAMIDE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING SAME, AND INTERMEDIATE USING SAME
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use
MXPA03008636A (es) Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application